Durán-Lobato M - Search Results

1

Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape.

Durán-Lobato M, López-Estévez AM, Cordeiro AS, Dacoba TG, Crecente-Campo J, Torres D, Alonso MJ. Durán-Lobato M, et al. Adv Drug Deliv Rev. 2021 Sep;176:113899. doi: 10.1016/j.addr.2021.113899. Epub 2021 Jul 24. Adv Drug Deliv Rev. 2021. PMID: 34314784 Free article. Review.

2

PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.

Niu Z, Samaridou E, Jaumain E, Coëne J, Ullio G, Shrestha N, Garcia J, Durán-Lobato M, Tovar S, Santander-Ortega MJ, Lozano MV, Arroyo-Jimenez MM, Ramos-Membrive R, Peñuelas I, Mabondzo A, Préat V, Teixidó M, Giralt E, Alonso MJ. Niu Z, et al. Among authors: duran lobato m. J Control Release. 2018 Apr 28;276:125-139. doi: 10.1016/j.jconrel.2018.03.004. Epub 2018 Mar 6. J Control Release. 2018. PMID: 29518466

3

Oral Delivery of Biologics for Precision Medicine.

Durán-Lobato M, Niu Z, Alonso MJ. Durán-Lobato M, et al. Adv Mater. 2020 Apr;32(13):e1901935. doi: 10.1002/adma.201901935. Epub 2019 Jun 20. Adv Mater. 2020. PMID: 31222910 Review.

4

Cannabinoids as Emergent Therapy Against COVID-19.

McGrail J, Martín-Banderas L, Durán-Lobato M. McGrail J, et al. Among authors: duran lobato m. Cannabis Cannabinoid Res. 2022 Oct;7(5):582-590. doi: 10.1089/can.2022.0018. Epub 2022 May 5. Cannabis Cannabinoid Res. 2022. PMID: 35512732 Free PMC article. Review.

5

Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies.

Martín-Banderas L, Alvarez-Fuentes J, Durán-Lobato M, Prados J, Melguizo C, Fernández-Arévalo M, Holgado MÁ. Martín-Banderas L, et al. Int J Nanomedicine. 2012;7:5793-806. doi: 10.2147/IJN.S34633. Epub 2012 Nov 23. Int J Nanomedicine. 2012. PMID: 23209365 Free PMC article.

6

Engineering of Δ9-tetrahydrocannabinol delivery systems based on surface modified-PLGA nanoplatforms.

Martín-Banderas L, Muñoz-Rubio I, Álvarez-Fuentes J, Durán-Lobato M, Arias JL, Holgado MÁ, Fernández-Arévalo M. Martín-Banderas L, et al. Among authors: duran lobato m. Colloids Surf B Biointerfaces. 2014 Nov 1;123:114-22. doi: 10.1016/j.colsurfb.2014.09.002. Epub 2014 Sep 16. Colloids Surf B Biointerfaces. 2014. PMID: 25262411

7

Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation.

Durán-Lobato M, Carrillo-Conde B, Khairandish Y, Peppas NA. Durán-Lobato M, et al. Biomacromolecules. 2014 Jul 14;15(7):2725-34. doi: 10.1021/bm500588x. Epub 2014 Jul 2. Biomacromolecules. 2014. PMID: 24955658 Free PMC article.

8

Enhanced cellular uptake and biodistribution of a synthetic cannabinoid loaded in surface-modified poly(lactic-co-glycolic acid) nanoparticles.

Durán-Lobato M, Muñoz-Rubio I, Holgado MA, Alvarez-Fuentes J, Fernández-Arévalo M, Martín-Banderas L. Durán-Lobato M, et al. J Biomed Nanotechnol. 2014 Jun;10(6):1068-79. doi: 10.1166/jbn.2014.1806. J Biomed Nanotechnol. 2014. PMID: 24749401

9

Receptor-targeted nanoparticles modulate cannabinoid anticancer activity through delayed cell internalization.

Durán-Lobato M, Álvarez-Fuentes J, Fernández-Arévalo M, Martín-Banderas L. Durán-Lobato M, et al. Sci Rep. 2022 Jan 25;12(1):1297. doi: 10.1038/s41598-022-05301-z. Sci Rep. 2022. PMID: 35079042 Free PMC article.

10

Cannabinoid-Based Ocular Therapies and Formulations.

Saraiva SM, Martín-Banderas L, Durán-Lobato M. Saraiva SM, et al. Among authors: duran lobato m. Pharmaceutics. 2023 Mar 27;15(4):1077. doi: 10.3390/pharmaceutics15041077. Pharmaceutics. 2023. PMID: 37111563 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page